Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1576 AL 1590

Predicting optimal deep brain stimulation parameters for Parkinson's disease using functional MRI and machine learning

Boutet A, Madhavan R, Elias GJB, Joel SE, Gramer R, Ranjan M, Paramanandam V, Xu D, Germann J, Loh A, Kalia SK, Hodaie M, Li B, Prasad S, Coblentz A, Munhoz RP, Ashe J, Kucharczyk W, Fasano A, Lozano AM.

Nat Commun. 2021 May 24;12(1):3043. doi: 10.1038/s41467-021-23311-9.

Cortical Thickness from MRI to Predict Conversion from Mild Cognitive Impairment to Dementia in Parkinson Disease: A Machine Learning-based Model

Shin NY, Bang M, Yoo SW, Kim JS, Yun E, Yoon U, Han K, Ahn KJ, Lee SK.

Radiology. 2021 Aug;300(2):390-399. doi: 10.1148/radiol.2021203383. Epub 2021 May 25.

Better Together: How Machine Learning Can Help Clinicians Determine If My Father Will Develop Parkinson Disease Dementia

Port JD.

Radiology. 2021 Aug;300(2):400-401. doi: 10.1148/radiol.2021210420. Epub 2021 May 25.

Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular Vesicles

Hong Z, Tian C, Stewart T, Aro P, Soltys D, Bercow M, Sheng L, Borden K, Khrisat T, Pan C, Zabetian CP, Peskind ER, Quinn JF, Montine TJ, Aasly J, Shi M, Zhang J.

Neurology. 2021 May 4;96(18):e2332-e2345. doi: 10.1212/WNL.0000000000011853. Epub 2021 Mar 23.

Gut Microbiota as a Mediator of Host Neuro-Immune Interactions: Implications in Neuroinflammatory Disorders

Caputi V, Popov J, Giron MC, O Apos Mahony S.

Mod Trends Psychiatry. 2021;32:40-57. doi: 10.1159/000510416. Epub 2021 May 6.

Production of Psychoactive Metabolites by Gut Bacteria

Wiley NC, Cryan JF, Dinan TG, Ross RP, Stanton C.

Mod Trends Psychiatry. 2021;32:74-99. doi: 10.1159/000510419. Epub 2021 May 6.

The Intersection of Parkinson's Disease, Viral Infections, and COVID-19

Rosen B, Kurtishi A, Vazquez-Jimenez GR, Møller SG.

Mol Neurobiol. 2021 Sep;58(9):4477-4486. doi: 10.1007/s12035-021-02408-8. Epub 2021 May 25.

Toll-like receptors in neuroinflammation, neurodegeneration, and alcohol-induced brain damage

Pascual M, Calvo-Rodriguez M, Núñez L, Villalobos C, Ureña J, Guerri C.

IUBMB Life. 2021 Jul;73(7):900-915. doi: 10.1002/iub.2510. Epub 2021 Jun 4.

Diffuse Large B-cell Lymphoma: Unexpected Uptake Observed on Cardiac 123I-MIBG Scintigraphy

Sakurada H, Koyasu S, Sugimoto A, Nakanishi E, Nakamoto Y.

Clin Nucl Med. 2021 Oct 1;46(10):850-852. doi: 10.1097/RLU.0000000000003737.

MRI Signs of Parkinson's Disease and Atypical Parkinsonism

Aludin S, Schmill LA.

Rofo. 2021 Dec;193(12):1403-1410. doi: 10.1055/a-1460-8795. Epub 2021 May 25.

New Horizons in the Treatment of Neurological Disorders with Tailorable Gold Nanoparticles

Farheen, Khan MA, Ashraf GM, Bilgrami AL, Rizvi MMA.

Curr Drug Metab. 2021;22(12):931-938. doi: 10.2174/1389200222666210525123416.

Pain in Parkinson's disease and the role of the subthalamic nucleus

Mostofi A, Morgante F, Edwards MJ, Brown P, Pereira EAC.

Brain. 2021 Jun 22;144(5):1342-1350. doi: 10.1093/brain/awab001.

Cardiovascular dysautonomia and cognition in Parkinson's Disease - a possible relationship

Kwaśniak-Butowska M, Dulski J, Pierzchlińska A, Białecka M, Wieczorek D, Sławek J.

Neurol Neurochir Pol. 2021;55(6):525-535. doi: 10.5603/PJNNS.a2021.0040. Epub 2021 May 26.

Essentials of Paroxysmal Supraventricular Tachycardia for the Pediatrician

Borquez AA, Williams MR.

Pediatr Ann. 2021 Mar;50(3):e113-e120. doi: 10.3928/19382359-20210217-01. Epub 2021 Mar 1.

Immunotherapies for Parkinson's Disease: Progression of Clinical Development

Teng JS, Ooi YY, Chye SM, Ling APK, Koh RY.

CNS Neurol Disord Drug Targets. 2021;20(9):802-813. doi: 10.2174/1871527320666210526160926.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias